<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title></journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2015.3242</article-id>
<article-id pub-id-type="publisher-id">mmr-11-06-4285</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Quercetin attenuates the effects of H<sub>2</sub>O<sub>2</sub> on endoplasmic reticulum morphology and tyrosinase export from the endoplasmic reticulum in melanocytes</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>GUAN</surname><given-names>CUIPING</given-names></name><xref ref-type="corresp" rid="c1-mmr-11-06-4285"/></contrib>
<contrib contrib-type="author">
<name><surname>XU</surname><given-names>WEN</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>HONG</surname><given-names>WEISONG</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>ZHOU</surname><given-names>MIAONI</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>LIN</surname><given-names>FUQUAN</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>FU</surname><given-names>LIFANG</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>LIU</surname><given-names>DONGYIN</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>XU</surname><given-names>AIE</given-names></name></contrib>
<aff id="af1-mmr-11-06-4285">Department of Dermatology, Third People&#x02019;s Hospital of Hangzhou, Hangzhou, Zhejiang 310009, P.R. China</aff></contrib-group>
<author-notes>
<corresp id="c1-mmr-11-06-4285">Correspondence to: Dr Cuiping Guan, Department of Dermatology, Third People&#x02019;s Hospital of Hangzhou, 38 Xihu Avenue, Building 1, Hangzhou, Zhejiang 310009, P.R. China, E-mail: <email>imgcp@hotmail.com</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2015</year></pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>01</month>
<year>2015</year></pub-date>
<volume>11</volume>
<issue>6</issue>
<fpage>4285</fpage>
<lpage>4290</lpage>
<history>
<date date-type="received">
<day>10</day>
<month>01</month>
<year>2014</year></date>
<date date-type="accepted">
<day>24</day>
<month>10</month>
<year>2014</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2015, Spandidos Publications</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>Swollen endoplasmic reticulum (ER) is commonly observed in the melanocytes of vitiligo patients; however, the cause and proteins involved in this remain to be elucidated. Oxidative stress has been reported to be involved in the pathogenesis of vitiligo and previous studies have demonstrated that hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) induced melanocyte apoptosis, whereas quercetin exhibited cytoprotective activities against the effects of H<sub>2</sub>O<sub>2</sub>. The aim of the present study was to further investigate the role of H<sub>2</sub>O<sub>2</sub> in the ER of melanocytes as well as its role in the export of tyrosinase from ER; in addition, the present study aimed to determine the mechanism by which quercetin protects against the effects of H<sub>2</sub>O<sub>2</sub>. The results demonstrated that melanocyte cells treated with H<sub>2</sub>O<sub>2</sub> presented with swollen ER; however, a normal ER configuration was observed in untreated cells as well as quercetin/H<sub>2</sub>O<sub>2</sub>-treated cells. Furthermore, H<sub>2</sub>O<sub>2</sub> inhibited tyrosinase export from the ER and decreased expression levels of tyrosinase; however, quercetin was found to attenuate the effects induced by H<sub>2</sub>O<sub>2</sub>. In conclusion, the results of the present study confirmed the hypothesis that H<sub>2</sub>O<sub>2</sub> induced ER dilation and hindered functional tyrosinase export from the ER of melanocytes. It was also found that quercetin significantly weakened these effects mediated by H<sub>2</sub>O<sub>2</sub>, therefore it may have the potential for use in the treatment of vitiligo.</p></abstract>
<kwd-group>
<kwd>quercetin</kwd>
<kwd>hydrogen peroxide</kwd>
<kwd>endoplasmic reticulum</kwd>
<kwd>tyrosinase</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Vitiligo is a prevalent disorder, affecting 0.5&#x02013;1% of the population worldwide, which results in depigmented areas of the skin (<xref rid="b1-mmr-11-06-4285" ref-type="bibr">1</xref>). The absence of melanocytes in the skin lesions was previously reported to be the key event in the pathogenesis of vitiligo (<xref rid="b2-mmr-11-06-4285" ref-type="bibr">2</xref>); however, the aetiology of vitiligo remains to be elucidated. Previous studies have suggested that oxidative stress may result in the loss of melanocytes (<xref rid="b3-mmr-11-06-4285" ref-type="bibr">3</xref>,<xref rid="b4-mmr-11-06-4285" ref-type="bibr">4</xref>); increased intracellular reactive oxygen species (ROS) production was observed in the epidermis of vitiligo patients (<xref rid="b5-mmr-11-06-4285" ref-type="bibr">5</xref>), which therefore indicates the presences of systemic oxidative stress in vitiligo (<xref rid="b6-mmr-11-06-4285" ref-type="bibr">6</xref>,<xref rid="b7-mmr-11-06-4285" ref-type="bibr">7</xref>). Accumulated oxidative stress leads to DNA damage, lipid and protein peroxidation and cell death (<xref rid="b8-mmr-11-06-4285" ref-type="bibr">8</xref>,<xref rid="b9-mmr-11-06-4285" ref-type="bibr">9</xref>). Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)-mediated oxidation was reported to result in inhibition of tyrosinase (<xref rid="b10-mmr-11-06-4285" ref-type="bibr">10</xref>) and the significant decrease in acetylcholine esterase (AChE) activity (<xref rid="b11-mmr-11-06-4285" ref-type="bibr">11</xref>). A previous study showed that antioxidants may be resistant to cell death mediated by oxidative stress. Green tea extract and quercetin were demonstrated to have potent cytoprotective effects on H<sub>2</sub>O<sub>2</sub>-induced cell death (<xref rid="b12-mmr-11-06-4285" ref-type="bibr">12</xref>); in addition, another study showed that quercetin inhibited H<sub>2</sub>O<sub>2</sub>-induced melanocyte apoptosis (<xref rid="b13-mmr-11-06-4285" ref-type="bibr">13</xref>). Furthermore, a double-blind placebo controlled trial revealed that oral supplementation with an antioxidant pool (AP)containing &#x003B1;-lipoic acid prior to and during narrowband ultraviolet B (NB-UVB) exposure significantly improves the clinical effectiveness of NB-UVB, reducing vitiligo-associated oxidative stress (<xref rid="b14-mmr-11-06-4285" ref-type="bibr">14</xref>).</p>
<p>Extensive dilation of the rough endoplasmic reticulum (RER) was observed in numerous vitiligo patients; however, the cause and the proteins involved remain to be elucidated (<xref rid="b15-mmr-11-06-4285" ref-type="bibr">15</xref>). A previous study demonstrated that swollen ER were present in melanocytes transfected with <italic>FBXO11</italic> siRNA; tyrosinase, the rate-limiting enzyme for melanin synthesis, was also reported to be regulated by the <italic>FBXO11</italic> gene (<xref rid="b16-mmr-11-06-4285" ref-type="bibr">16</xref>). Furthermore, H<sub>2</sub>O<sub>2</sub> was found to induce partially damaged plasma membranes, swollen RER and swollen or deformed mitochondria with ruptured cristae (<xref rid="b17-mmr-11-06-4285" ref-type="bibr">17</xref>). Therefore, it was suggested that H<sub>2</sub>O<sub>2</sub> may induce dilated ER and melanocyte dysfunction.</p>
<p>The present study aimed to evaluate the effects of H<sub>2</sub>O<sub>2</sub> on the morphology of melanocyte ER and the export of tyrosinase from the ER, as well as to determine the mechanisms underlying the protective role of quercetin against the effects of H<sub>2</sub>O<sub>2</sub>.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<sec>
<title>Reagents</title>
<p>Culture medium and supplements were obtained from Gibco-BRL (Carlsbad, CA, USA), with the exception of recombinant human basic fibroblast growth factor (bFGF), isobutylmethylxanthine (IBMX) and cholera toxin (CT), which were purchased from PeproTech, Inc. (Rocky Hill, NJ, USA). H<sub>2</sub>O<sub>2</sub> and quercetin were purchased from Sigma-Aldrich (St. Louis, MO, USA). Mouse monoclonal anti-tyrosinase and rabbit polyclonal anti-calreticulin antibodies were purchased from Abcam (Cambridge, MA, USA), anti-&#x003B2;-actin mouse monoclonal antibody was from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA), Alexa Fluor<sup>&#x000AE;</sup> 488 donkey anti-mouse Immunoglobulin G (IgG; heavy and light chain, H+L) and Alexa Fluor<sup>&#x000AE;</sup> 594 donkey anti-rabbit IgG (H+L) from Life Technologies (Grand Island, NY, USA) and IRDye 680RD goat anti-mouse IgG highly cross adsorbed was from LI-COR Biosciences (Lincoln, NE, USA).</p></sec>
<sec>
<title>Cell culture</title>
<p>Human epidermal melanocytes were obtained from normal foreskins as previously described (<xref rid="b18-mmr-11-06-4285" ref-type="bibr">18</xref>). Written informed consent was obtained from the patients and the study was approved by the ethics committee of the Third People&#x02019;s Hospital of Hangzhou (Hangzhou, China). In brief, the samples were incubated in a solution of 0.25% trypsin and 0.2% ethylenediamine tetraacetic acid for 20 h; trypsinization was terminated by the addition of Dulbecco&#x02019;s modified Eagle&#x02019;s medium (Gibco-BRL) containing 10% fetal bovine serum (FBS; Gibco-BRL). Melanocytes were then scraped from the epidermis, washed with phosphate-buffered saline (PBS) and centrifuged at 100 &#x000D7; g for 5 min. The pellet was resuspended in Hu16 medium (F12 medium with 20 ng/ml bFGF, 20 <italic>&#x003BC;</italic>g/ml IBMX, 10 ng/ml CT, 50 <italic>&#x003BC;</italic>g/ml gentamicin and 10% FBS). Cells were incubated in a humidified 95% air/5% CO<sub>2</sub> atmosphere at 37&#x000B0;C. Geneticin was added to the medium (100 <italic>&#x003BC;</italic>g/ml) three days later in order to eliminate contaminating cells. Primary cultures were stored until they reached 80% confluence and then the melanocytes were detached using 0.125% trypsin/0.01 M EDTA solution, centrifuged at 100 &#x000D7; g for 5 min, resuspended and then seeded into culture flasks for subculture. Melanocytes used in the present study were of passage 2&#x02013;3.</p></sec>
<sec>
<title>Exposure to H<sub>2</sub>O<sub>2</sub></title>
<p>In order to evaluate effect of H<sub>2</sub>O<sub>2</sub> on melanocytes, cultured cells were seeded at 1&#x000D7;10<sup>4</sup> per well in 96-well plates at different H<sub>2</sub>O<sub>2</sub> concentrations (0&#x02013;400 <italic>&#x003BC;</italic>M) for 24 h. Cell viability was then assessed using an MTT assay kit (Promega, Sunnyvale, CA, USA).</p></sec>
<sec>
<title>Treatment of quercetin</title>
<p>In order to investigate the cytoprotective activity of quercetin, cells (2&#x000D7;10<sup>5</sup>/well) were seeded onto six-well plates. Following serum starvation for 24 h, cells were pretreated with quercetin (0&#x02013;200 <italic>&#x003BC;</italic>M dissolved in NaOH) for 24 h, H<sub>2</sub>O<sub>2</sub> was then added to each well and incubated for 24 h. Cell viabilities were determined using an MTT assay.</p></sec>
<sec>
<title>Cell viability assay</title>
<p>MTT assays were used to assess cell viability in melanocytes following H<sub>2</sub>O<sub>2</sub> and quercetin treatment. Following treatment, 10 <italic>&#x003BC;</italic>l MTT (10 mg/ml) was added to cells seeded in 96-well plates and incubated for 4 h, then 100 <italic>&#x003BC;</italic>l dimethyl sulfoxide was added for 15 min to dissolve. The absorbance value was measured at 490 nm using a microplate spectrophotometer (SoftMax Pro5; Molecular Devices, LLC, Sunnyvale, CA, USA).</p></sec>
<sec>
<title>Intracellular ROS measurement</title>
<p>ROS levels were determined by measuring the oxidative conversion of 2&#x02032;,7&#x02032;-dichloro-fluorescin diacetate (DCFH-DA) into the fluorescent compound dichlorofluorescin (DCF) using a ROS assay kit (Beyotime Insitute of Biotechnology, Jiangsu, China). In brief, 1&#x000D7;10<sup>4</sup> cells/well were seeded into a 96-well plate and then the medium was replaced with serum-free medium for 24 h starvation. Cells from each well were then incubated with 10 <italic>&#x003BC;</italic>M DCFH-DA for 20 min at 37&#x000B0;C. Cells were treated with quercetin or NaOH for 30 min and then H<sub>2</sub>O<sub>2</sub> was added to each well, except those containing the untreated group, and the cells were incubated for 30 min. For the estimation of intracellular ROS, DCF fluorescence was determined at 485 nm excitation and 520 nm emission using a flow cytometer (BD FACSCalibur&#x02122;; BD Biosciences, Franklin Lakes, NJ, USA). Three independent experiments were performed.</p></sec>
<sec>
<title>Electron microscopy observation</title>
<p>Cells were seeded into a six-well plate and the medium was replaced with serum-free medium for 24 h starvation. Cells were pretreated with 0.01 <italic>&#x003BC;</italic>M NaOH or 25 <italic>&#x003BC;</italic>M quercetin for 24 h at 37&#x000B0;C; 200 <italic>&#x003BC;</italic>M H<sub>2</sub>O<sub>2</sub> was then added to each well, except the untreated group, and incubated for 24 h. ER configuration was observed using electron microscopy as previously described (<xref rid="b16-mmr-11-06-4285" ref-type="bibr">16</xref>). In brief, cells were collected and fixed with 2.5% glutaraldehyde in 0.1 M PBS at 4&#x000B0;C overnight; cells were then post-fixed with 1% OsO<sub>4</sub> in 0.1 M PBS at 4&#x000B0;C for 1 h. Cells were then embedded in 5% agarose (Sigma-Aldrich) and cut into 2&#x02013;3-mm<sup>2</sup> blocks, dehydrated in a graded series of ethanol and embedded in epoxy resin (West System, Bay City, MI, USA). Ultrathin sections were stained with uranyl acetate (Sigma-Aldrich) and lead citrate (Sigma-Aldrich) and were examined using a transmission electron microscope (JEM-1230; JEOL, Ltd., Tokyo, Japan).</p></sec>
<sec>
<title>Immunofluorescence assay</title>
<p>In order to examine the co-localization of tyrosinase and calreticulin, cells were grown in six-well plates containing coverslips, with various treatments. Cells were then fixed with 4% formaldehyde in PBS for 30 min. Anti-tyrosinase and anti-calreticulin antibodies were used at 10 <italic>&#x003BC;</italic>g/ml in buffer (0.5% BSA in PBS) and incubated with the coverslips for 1 h. Cells were then incubated with the secondary antibodies, Alexa Fluor<sup>&#x000AE;</sup> 488 donkey anti-mouse IgG (H+L) for tyrosinase and Alexa Fluor<sup>&#x000AE;</sup> 594 donkey anti-rabbit IgG (H+L) for calreticulin, at a dilution of 1:500 in PBS for 30 min at room temperature. Cover slips were washed three times in PBS for 5 mins each, mounted using a mounting medium and observed with confocal laser scanning microscope (TCS SP2; Leica Microsystems, Wetzlar, Germany).</p></sec>
<sec>
<title>Western blot analysis of tyrosinase</title>
<p>Total proteins were isolated from cells and separated on a 10% polyacrylamide gel. Proteins were measured using western blot analysis with mouse antibodies against tyrosinase, followed by incubation with IRDye 680RD goat anti-mouse IgG highly cross adsorbed (1:10,000) for 1 h. &#x003B2;-actin was used as the internal control. An infrared imaging system, Licor Odyssey (LI-COR Biosciences), was used to visualize the protein bands and the relative intensities of bands were quantified using Image Studio for Licor Odyssey CLx and Classic (LI-COR Biosciences).</p></sec>
<sec>
<title>Statistical analysis</title>
<p>Values are presented as the mean &#x000B1; standard deviation. Comparisons among groups were analyzed by a one-way analysis of variance using SPSS Version 13.0 (SPSS Inc., Chicago, IL, USA). P&lt;0.05 and P&lt;0.01 were considered to indicate a statistically significant difference.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Cell viability in the presence and absence of H<sub>2</sub>O<sub>2</sub></title>
<p>Human melanocytes and H<sub>2</sub>O<sub>2</sub> were used as a model for oxidative stress in order to investigate cell viability using an MTT assay. Cells were treated with different concentrations of H<sub>2</sub>O<sub>2</sub> (0&#x02013;400 <italic>&#x003BC;</italic>M) for 24 h, and cell viability was measured. As shown in <xref rid="f1-mmr-11-06-4285" ref-type="fig">Fig. 1</xref>, the viability of H<sub>2</sub>O<sub>2</sub>-treated cells significantly decreased in a dose-dependent manner. Following treatment with 200 <italic>&#x003BC;</italic>M H<sub>2</sub>O<sub>2</sub>, cell viability was reduced by ~50%, this was considered to be the optimum concentration of H<sub>2</sub>O<sub>2</sub> and was used for subsequent experiments.</p></sec>
<sec>
<title>Quercetin protects against H<sub>2</sub>O<sub>2</sub>-induced cell death</title>
<p>In order to investigate the effect of quercetin on H<sub>2</sub>O<sub>2</sub>-induced oxidative stress, H<sub>2</sub>O<sub>2</sub>-treated cells were pretreated with different concentrations of quercetin. In contrast to the H<sub>2</sub>O<sub>2</sub>-treated cells, quercetin was observed to have a minor, but not significant, protective effect at concentrations of 6.25 and 12.5 <italic>&#x003BC;</italic>M; however, quercetin concentrations of 25&#x02013;200 <italic>&#x003BC;</italic>M exhibited significant protective effects against H<sub>2</sub>O<sub>2</sub>-induced cell death (<xref rid="f2-mmr-11-06-4285" ref-type="fig">Fig. 2</xref>). Therefore, 25 <italic>&#x003BC;</italic>M quercetin was selected to be used for following experiments.</p></sec>
<sec>
<title>ROS production in melanocytes under different conditions</title>
<p>ROS production was evaluated in melanocytes following exposure to quercetin or NaOH in the presence or absence of H<sub>2</sub>O<sub>2</sub>. As shown in <xref rid="f3-mmr-11-06-4285" ref-type="fig">Fig. 3</xref>, H<sub>2</sub>O<sub>2</sub> and NaOH/H<sub>2</sub>O<sub>2</sub> treatments resulted in an 0.5 fold increase in ROS production compared with that of the untreated control levels (P&lt;0.01); however, no significant difference was identified between these two groups (P=0.123). In addition, ROS levels in the quercetin/H<sub>2</sub>O<sub>2</sub> group demonstrated a significant decrease compared with those of the untreated control group (P=0.022).</p></sec>
<sec>
<title>Effect of quercetin and H<sub>2</sub>O<sub>2</sub> on ER configuration</title>
<p>ER modality was analyzed using electron microscopy in order to observe the effects of different conditions on melanoctyes. As shown in <xref rid="f4-mmr-11-06-4285" ref-type="fig">Fig. 4</xref>, dilated ER was observed in H<sub>2</sub>O<sub>2</sub>- and NaOH/H<sub>2</sub>O<sub>2</sub>-treated cells. In untreated cells, ER configuration was shown to be normal. Notably, normal ER configuration was also observed in quercetin/H<sub>2</sub>O<sub>2</sub>-treated cells. This therefore suggested that quercetin was able to prevent H<sub>2</sub>O<sub>2</sub>-induced ER dilation.</p></sec>
<sec>
<title>Co-localization of tyrosinase and calreticulum</title>
<p>Confocal laser scanning microscopy was performed in order to assess the co-localization of tyrosinase, the rate-limiting enzyme for melanin synthesis, and calreticulin, an ER marker protein. In untreated cells and quercetin/H<sub>2</sub>O<sub>2</sub>-treated cells, tyrosinase fluorescence was beyond the fluorescence marked by calreticulin, which indicated that tyrosinase was effectively exported from the ER. However, in H<sub>2</sub>O<sub>2</sub>- and NaOH/H<sub>2</sub>O<sub>2</sub>-treated cells, the distribution of tyrosinase fluorescence was pronounced in ER marked by calreticulinin, which suggested that the export of tyrosinase from the ER was disordered (<xref rid="f5-mmr-11-06-4285" ref-type="fig">Fig. 5</xref>); this therefore indicated that H<sub>2</sub>O<sub>2</sub> interfered with the functional export of tyrosinase from the ER.</p></sec>
<sec>
<title>Quercetin attenuates H<sub>2</sub>O<sub>2</sub>-induced inhibition of tyrosinase expression</title>
<p>Western blot analysis was used to determined the expression levels of tyrosinase in melanocytes. As shown in <xref rid="f6-mmr-11-06-4285" ref-type="fig">Fig. 6</xref>, tyrosinase expression was significantly increased in the quercetin/H<sub>2</sub>O<sub>2</sub> group compared with that of the untreated group (P=0.046). By contrast, tyrosinase expression was significantly decreased in the H<sub>2</sub>O<sub>2</sub> (P&lt;0.01) and NaOH/H<sub>2</sub>O<sub>2</sub> groups (P&lt;0.01) compared with that of the control; however, no significant differences were observed between these two groups (P=0.185). This therefore indicated that quercetin attenuated the H<sub>2</sub>O<sub>2</sub>-induced inhibition of tyrosinase expression.</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>H<sub>2</sub>O<sub>2</sub> was previously demonstrated to inhibit tyrosinase expression and melanocyte viability; in addition, quercetin was found to protect melanocytes from H<sub>2</sub>O<sub>2</sub>-mediated oxidative stress (<xref rid="b13-mmr-11-06-4285" ref-type="bibr">13</xref>). This previous study primarily focused on melanocyte viability; however, in the present study, the effects of H<sub>2</sub>O<sub>2</sub> on the tyrosinase export from the ER and morphology of the ER, as well as the attenuation of H<sub>2</sub>O<sub>2</sub>-induced oxidative stress by quercetin, were further investigated.</p>
<p>The present study determined that 200 <italic>&#x003BC;</italic>M H<sub>2</sub>O<sub>2</sub> and 25 <italic>&#x003BC;</italic>M quercetin, with incubation for 24 h were the optimum parameters for the experiments performed. ROS levels in melanocytes of different treatment groups were determined using DCFH-DA. ROS production was found to increase 1.5 fold in the H<sub>2</sub>O<sub>2</sub>-treated group compared with that of the untreated group, whereas cells that underwent quercetin/H<sub>2</sub>O<sub>2</sub> treatment demonstrated comparative ROS levels with those of the untreated group. This therefore suggested that quercetin attenuated the H<sub>2</sub>O<sub>2</sub>-induced increase in ROS levels. The effects of H<sub>2</sub>O<sub>2</sub> on ER modality in melanocytes was observed using electron microscopy; markedly dilated ER were observed in the H<sub>2</sub>O<sub>2</sub>-treated group, whereas normal ER configuration was found in the quercetin/H<sub>2</sub>O<sub>2</sub>-treated and untreated groups. This therefore indicated H<sub>2</sub>O<sub>2</sub> induced ER dilation in melanocytes, which was prevented by quercetin treatment. The ER is a vital and highly dynamic organelle present in all eukaryotic cells; a multitude of parameters inside the cell and in its microenvironment significantly influence the complex functions of ER. Factors including the availability of glucose (hypoglycemia), hyperthermia, calcium levels and the redox milieu, impact and disturb the proper functioning of the ER, resulting in ER stress, which results in improper protein folding in the lumen of the ER (<xref rid="b19-mmr-11-06-4285" ref-type="bibr">19</xref>,<xref rid="b20-mmr-11-06-4285" ref-type="bibr">20</xref>). Pronounced dilation of the ER lumen is a well established ultrastructural response to ER stress; under which mammalian cells have been reported to expand their ER volume several fold (<xref rid="b21-mmr-11-06-4285" ref-type="bibr">21</xref>,<xref rid="b22-mmr-11-06-4285" ref-type="bibr">22</xref>). The results of the present study demonstrated that ER volume of melanocytes increased 2.02&#x000B1;0.07 fold following H<sub>2</sub>O<sub>2</sub> treatment, therefore indicating that H<sub>2</sub>O<sub>2</sub> disturbed the proper function of the ER, while quercetin attenuated the effects of H<sub>2</sub>O<sub>2</sub>.</p>
<p>Tyrosinase is the core enzyme that catalyzes melanogenesis in melanocytes. Abnormalities in the post-translational processing of tyrosinase have been implicated in several depigmentation diseases (<xref rid="b23-mmr-11-06-4285" ref-type="bibr">23</xref>). Stagnation of tyrosinase in ER was found to be relevant to the phenotype of pigment loss in melanoma (<xref rid="b24-mmr-11-06-4285" ref-type="bibr">24</xref>). The dysfunctional transportation of tyrosinase from the golgi to melanosomes leads to different diseases, including generalized albinism types 2 and 4 as well as Hermansky-Pudlak syndrome (<xref rid="b25-mmr-11-06-4285" ref-type="bibr">25</xref>&#x02013;<xref rid="b27-mmr-11-06-4285" ref-type="bibr">27</xref>). Therefore, in the present study, in order to evaluate protein processing and transport in the ER of melanocytes in different treatment groups, confocal laser scanning microscopy was performed to assess the co-localization of tyrosinase and calreticulin. The result demonstrated that tyrosinase and calreticulin expression were both localized in the ER of H<sub>2</sub>O<sub>2</sub>- and NaOH/H<sub>2</sub>O<sub>2</sub>-treated cells. A large amount of tyrosinase was not observed at the endoplasmic reticulum marked by calreticulin in untreated and quercetin/H<sub>2</sub>O<sub>2</sub>-treated cells. These results suggested that H<sub>2</sub>O<sub>2</sub> hindered tyrosinase export from the ER; however, quercetin pretreatment enabled cells to maintain the effective export of tyrosinase from the ER. Furthermore, comparative expression levels of tyrosinase were observed in the quercetin/H<sub>2</sub>O<sub>2</sub>-treated and untreated groups; however, tyrosinase expression was significantly decreased in the H<sub>2</sub>O<sub>2</sub> and NaOH/H<sub>2</sub>O<sub>2</sub> groups.</p>
<p>Numerous studies have reported that antioxidants may protect melanocytes against oxidative stress; green tea extract was found to protect cellular membranes against t-butylhydroperoxide-induced oxidative damage (<xref rid="b28-mmr-11-06-4285" ref-type="bibr">28</xref>), and a combination of vitamins C and E demonstrated a protective effect against ultraviolet radiation (<xref rid="b29-mmr-11-06-4285" ref-type="bibr">29</xref>,<xref rid="b30-mmr-11-06-4285" ref-type="bibr">30</xref>). Quercetin is found in a variety of plant-based foods, including red onions, red grapes and a certain berries (<xref rid="b31-mmr-11-06-4285" ref-type="bibr">31</xref>). The potential chemopreventive effects of quercetin have been attributed to various mechanisms, including its antioxidative activity as well as its capacity to inhibit enzymes that activate carcinogens (resulting in the modification of signal transduction pathways) and interact with and regulate cell receptors and other proteins (<xref rid="b32-mmr-11-06-4285" ref-type="bibr">32</xref>). The results of the present study demonstrated that quercetin protected melanocytes from the effects of H<sub>2</sub>O<sub>2</sub> on the morphology of ER, tyrosinase export from the ER and tyrosinase expression.</p>
<p>In conclusion, the results of the present study showed that H<sub>2</sub>O<sub>2</sub> induced the dilation of ER lumina and hindered the functional export of tyrosinase from the ER, while quercetin attenuated these effects induced by H<sub>2</sub>O<sub>2</sub>. To the best of our knowledge, the present study provided the first evidence that H<sub>2</sub>O<sub>2</sub> has an important role on the ER morphology of melanocytes and functional export of tyrosinase from ER. These results may aid in elucidating the potential effect of antioxidants on the ultrastructure of melanocytes.</p></sec></body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The present study was supported partly by grants from the National Natural Science Foundation of China (grant nos. 30800563 and 81071294), the Zhejiang Provincial Natural Science Foundation of China (grant nos. Y2101132, Z2100973, LY12H11008 and LY12H11009), the Science Technology Department of Zhejiang Province (grant no. 2013C33093) and the Hangzhou Science and Technology project (grant no. 20092133W04). Additionally, the authors would like to acknowledge the financial support from the State Clinical Key Specialty Construction Project and Zhejiang Provincial Program for the Cultivation of High-level Health talents.</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-mmr-11-06-4285"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ta&#x000EF;eb</surname><given-names>A</given-names></name><name><surname>Picardo</surname><given-names>M</given-names></name><collab>VETF Members</collab></person-group><article-title>The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force</article-title><source>Pigment Cell Res</source><volume>20</volume><fpage>27</fpage><lpage>35</lpage><year>2007</year><pub-id pub-id-type="doi">10.1111/j.1600-0749.2006.00355.x</pub-id><pub-id pub-id-type="pmid">17250545</pub-id></element-citation></ref>
<ref id="b2-mmr-11-06-4285"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Poole</surname><given-names>IC</given-names></name><name><surname>Das</surname><given-names>PK</given-names></name><name><surname>van den Wijngaard</surname><given-names>RM</given-names></name><name><surname>Bos</surname><given-names>JD</given-names></name><name><surname>Westerhof</surname><given-names>W</given-names></name></person-group><article-title>Review of the etiopathomechanism of vitiligo: a convergence theory</article-title><source>Exp Dermatol</source><volume>2</volume><fpage>145</fpage><lpage>153</lpage><year>1993</year><pub-id pub-id-type="doi">10.1111/j.1600-0625.1993.tb00023.x</pub-id><pub-id pub-id-type="pmid">8162332</pub-id></element-citation></ref>
<ref id="b3-mmr-11-06-4285"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schallreuter</surname><given-names>KU</given-names></name></person-group><article-title>Successful treatment of oxidative stress in vitiligo</article-title><source>Skin Pharmacol Appl Skin Physiol</source><volume>12</volume><fpage>132</fpage><lpage>138</lpage><year>1999</year><pub-id pub-id-type="doi">10.1159/000029867</pub-id><pub-id pub-id-type="pmid">10393521</pub-id></element-citation></ref>
<ref id="b4-mmr-11-06-4285"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maresca</surname><given-names>V</given-names></name><name><surname>Roccella</surname><given-names>M</given-names></name><name><surname>Roccella</surname><given-names>F</given-names></name><etal/></person-group><article-title>Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo</article-title><source>J Invest Dermatol</source><volume>109</volume><fpage>310</fpage><lpage>313</lpage><year>1997</year><pub-id pub-id-type="doi">10.1111/1523-1747.ep12335801</pub-id><pub-id pub-id-type="pmid">9284096</pub-id></element-citation></ref>
<ref id="b5-mmr-11-06-4285"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dell&#x02019;Anna</surname><given-names>ML</given-names></name><name><surname>Maresca</surname><given-names>V</given-names></name><name><surname>Briganti</surname><given-names>S</given-names></name><etal/></person-group><article-title>Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo</article-title><source>J Invest Dermatol</source><volume>117</volume><fpage>908</fpage><lpage>913</lpage><year>2001</year><pub-id pub-id-type="doi">10.1046/j.0022-202x.2001.01459.x</pub-id></element-citation></ref>
<ref id="b6-mmr-11-06-4285"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schallreuter</surname><given-names>KU</given-names></name><name><surname>Wood</surname><given-names>JM</given-names></name><name><surname>Berger</surname><given-names>J</given-names></name></person-group><article-title>Low catalase levels in the epidermis of patients with vitiligo</article-title><source>J Invest Dermatol</source><volume>97</volume><fpage>1081</fpage><lpage>1085</lpage><year>1991</year><pub-id pub-id-type="doi">10.1111/1523-1747.ep12492612</pub-id><pub-id pub-id-type="pmid">1748819</pub-id></element-citation></ref>
<ref id="b7-mmr-11-06-4285"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sravani</surname><given-names>PV</given-names></name><name><surname>Babu</surname><given-names>NK</given-names></name><name><surname>Gopal</surname><given-names>KV</given-names></name><etal/></person-group><article-title>Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin</article-title><source>Indian J Dermatol Venereol Leprol</source><volume>75</volume><fpage>268</fpage><lpage>271</lpage><year>2009</year><pub-id pub-id-type="doi">10.4103/0378-6323.48427</pub-id><pub-id pub-id-type="pmid">19439879</pub-id></element-citation></ref>
<ref id="b8-mmr-11-06-4285"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salem</surname><given-names>MM</given-names></name><name><surname>Shalbaf</surname><given-names>M</given-names></name><name><surname>Gibbons</surname><given-names>NC</given-names></name><etal/></person-group><article-title>Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H<sub>2</sub>O<sub>2</sub>-mediated oxidation: a possible repair mechanism for DNA damage</article-title><source>FASEB J</source><volume>23</volume><fpage>3790</fpage><lpage>3807</lpage><year>2009</year><pub-id pub-id-type="doi">10.1096/fj.09-132621</pub-id><pub-id pub-id-type="pmid">19641144</pub-id></element-citation></ref>
<ref id="b9-mmr-11-06-4285"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giovannelli</surname><given-names>L</given-names></name><name><surname>Bellandi</surname><given-names>S</given-names></name><name><surname>Pitozzi</surname><given-names>V</given-names></name><etal/></person-group><article-title>Increased oxidative DNA damage in mononuclear leukocytes in vitiligo</article-title><source>Mutat Res</source><volume>556</volume><fpage>101</fpage><lpage>106</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.mrfmmm.2004.07.005</pub-id><pub-id pub-id-type="pmid">15491637</pub-id></element-citation></ref>
<ref id="b10-mmr-11-06-4285"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westerhof</surname><given-names>W</given-names></name><name><surname>d&#x02019;Ischia</surname><given-names>M</given-names></name></person-group><article-title>Vitiligo puzzle: the pieces fall in place</article-title><source>Pigment Cell Res</source><volume>20</volume><fpage>345</fpage><lpage>359</lpage><year>2007</year><pub-id pub-id-type="pmid">17850508</pub-id></element-citation></ref>
<ref id="b11-mmr-11-06-4285"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schallreuter</surname><given-names>KU</given-names></name><name><surname>Elwary</surname><given-names>SM</given-names></name><name><surname>Gibbons</surname><given-names>NC</given-names></name><name><surname>Rokos</surname><given-names>H</given-names></name><name><surname>Wood</surname><given-names>JM</given-names></name></person-group><article-title>Activation/deactivation of acetylcholinesterase by H<sub>2</sub>O<sub>2</sub>: more evidence for oxidative stress in vitiligo</article-title><source>Biochem Biophys Res Commun</source><volume>315</volume><fpage>502</fpage><lpage>508</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2004.01.082</pub-id><pub-id pub-id-type="pmid">14766237</pub-id></element-citation></ref>
<ref id="b12-mmr-11-06-4285"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>YM</given-names></name><name><surname>Choi</surname><given-names>YG</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Cytoprotective effect of green tea extract and quercetin against hydrogen peroxide-induced oxidative stress</article-title><source>Arch Pharm Res</source><volume>28</volume><fpage>1251</fpage><lpage>1256</lpage><year>2005</year><pub-id pub-id-type="doi">10.1007/BF02978208</pub-id><pub-id pub-id-type="pmid">16350851</pub-id></element-citation></ref>
<ref id="b13-mmr-11-06-4285"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagata</surname><given-names>H</given-names></name><name><surname>Takekoshi</surname><given-names>S</given-names></name><name><surname>Takeyama</surname><given-names>R</given-names></name><name><surname>Homma</surname><given-names>T</given-names></name><name><surname>Yoshiyuki Osamura</surname><given-names>R</given-names></name></person-group><article-title>Quercetin enhances melanogenesis by increasing the activity and synthesis of tyrosinase in human melanoma cells and in normal human melanocytes</article-title><source>Pigment Cell Res</source><volume>17</volume><fpage>66</fpage><lpage>73</lpage><year>2004</year><pub-id pub-id-type="doi">10.1046/j.1600-0749.2003.00113.x</pub-id><pub-id pub-id-type="pmid">14717847</pub-id></element-citation></ref>
<ref id="b14-mmr-11-06-4285"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dell&#x02019;Anna</surname><given-names>ML</given-names></name><name><surname>Mastrofrancesco</surname><given-names>A</given-names></name><name><surname>Sala</surname><given-names>R</given-names></name><etal/></person-group><article-title>Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial</article-title><source>Clin Exp Dermatol</source><volume>32</volume><fpage>631</fpage><lpage>636</lpage><year>2007</year><pub-id pub-id-type="doi">10.1111/j.1365-2230.2007.02514.x</pub-id></element-citation></ref>
<ref id="b15-mmr-11-06-4285"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boissy</surname><given-names>RE</given-names></name><name><surname>Liu</surname><given-names>YY</given-names></name><name><surname>Medrano</surname><given-names>EE</given-names></name><name><surname>Nordlund</surname><given-names>JJ</given-names></name></person-group><article-title>Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients</article-title><source>J Invest Dermatol</source><volume>97</volume><fpage>395</fpage><lpage>404</lpage><year>1991</year><pub-id pub-id-type="doi">10.1111/1523-1747.ep12480976</pub-id><pub-id pub-id-type="pmid">1875040</pub-id></element-citation></ref>
<ref id="b16-mmr-11-06-4285"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><etal/></person-group><article-title>The role of VIT1/FBXO11 in the regulation of apoptosis and tyrosinase export from endoplasmic reticulum in cultured melanocytes</article-title><source>Int J Mol Med</source><volume>26</volume><fpage>57</fpage><lpage>65</lpage><year>2010</year><pub-id pub-id-type="pmid">20514423</pub-id></element-citation></ref>
<ref id="b17-mmr-11-06-4285"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jinbo</surname><given-names>L</given-names></name><name><surname>Zhiyuan</surname><given-names>L</given-names></name><name><surname>Zhijian</surname><given-names>Z</given-names></name><name><surname>WenGe</surname><given-names>D</given-names></name></person-group><article-title>Olfactory ensheathing cell-conditioned medium protects astrocytes exposed to hydrogen peroxide stress</article-title><source>Cell Mol Neurobiol</source><volume>33</volume><fpage>699</fpage><lpage>705</lpage><year>2013</year><pub-id pub-id-type="doi">10.1007/s10571-013-9937-4</pub-id><pub-id pub-id-type="pmid">23584685</pub-id></element-citation></ref>
<ref id="b18-mmr-11-06-4285"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>WS</given-names></name><name><surname>Hu</surname><given-names>DN</given-names></name><name><surname>Qian</surname><given-names>GP</given-names></name><name><surname>McCormick</surname><given-names>SA</given-names></name><name><surname>Xu</surname><given-names>AE</given-names></name></person-group><article-title>Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation</article-title><source>Br J Dermatol</source><volume>165</volume><fpage>520</fpage><lpage>525</lpage><year>2011</year><pub-id pub-id-type="pmid">21564070</pub-id></element-citation></ref>
<ref id="b19-mmr-11-06-4285"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>JD</given-names></name><name><surname>Kaufman</surname><given-names>RJ</given-names></name></person-group><article-title>The endoplasmic reticulum and the unfolded protein response</article-title><source>Semin Cell Dev Biol</source><volume>18</volume><fpage>716</fpage><lpage>731</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.semcdb.2007.09.003</pub-id><pub-id pub-id-type="pmid">18023214</pub-id><pub-id pub-id-type="pmcid">2706143</pub-id></element-citation></ref>
<ref id="b20-mmr-11-06-4285"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Walter</surname><given-names>P</given-names></name></person-group><article-title>Signal integration in the endoplasmic reticulum unfolded protein response</article-title><source>Nat Rev Mol Cell Biol</source><volume>8</volume><fpage>519</fpage><lpage>529</lpage><year>2007</year><pub-id pub-id-type="doi">10.1038/nrm2199</pub-id><pub-id pub-id-type="pmid">17565364</pub-id></element-citation></ref>
<ref id="b21-mmr-11-06-4285"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartley</surname><given-names>T</given-names></name><name><surname>Siva</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>E</given-names></name><etal/></person-group><article-title>Endoplasmic reticulum stress response in an INS-1 pancreatic beta-cell line with inducible expression of a folding-deficient proinsulin</article-title><source>BMC Cell Biol</source><volume>11</volume><fpage>59</fpage><year>2010</year><pub-id pub-id-type="doi">10.1186/1471-2121-11-59</pub-id><pub-id pub-id-type="pmid">20659334</pub-id><pub-id pub-id-type="pmcid">2921384</pub-id></element-citation></ref>
<ref id="b22-mmr-11-06-4285"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuber</surname><given-names>C</given-names></name><name><surname>Fan</surname><given-names>JY</given-names></name><name><surname>Guhl</surname><given-names>B</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name></person-group><article-title>Misfolded proinsulin accumulates in expanded pre-Golgi intermediates and endoplasmic reticulum subdomains in pancreatic beta cells of Akita mice</article-title><source>FASEB J</source><volume>18</volume><fpage>917</fpage><lpage>919</lpage><year>2004</year><pub-id pub-id-type="pmid">15033933</pub-id></element-citation></ref>
<ref id="b23-mmr-11-06-4285"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyofuku</surname><given-names>K</given-names></name><name><surname>Wada</surname><given-names>I</given-names></name><name><surname>Valencia</surname><given-names>JC</given-names></name><name><surname>Kushimoto</surname><given-names>T</given-names></name><name><surname>Ferrans</surname><given-names>VJ</given-names></name><name><surname>Hearing</surname><given-names>VJ</given-names></name></person-group><article-title>Oculocutaneous albinism types 1 and 3 are ER retention diseases: Mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins</article-title><source>Faseb J</source><volume>15</volume><fpage>2149</fpage><lpage>2161</lpage><year>2001</year><pub-id pub-id-type="doi">10.1096/fj.01-0216com</pub-id><pub-id pub-id-type="pmid">11641241</pub-id></element-citation></ref>
<ref id="b24-mmr-11-06-4285"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halaban</surname><given-names>R</given-names></name><name><surname>Cheng</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells</article-title><source>Proc Natl Acad Sci USA</source><volume>94</volume><fpage>6210</fpage><lpage>6215</lpage><year>1997</year><pub-id pub-id-type="doi">10.1073/pnas.94.12.6210</pub-id><pub-id pub-id-type="pmid">9177196</pub-id><pub-id pub-id-type="pmcid">21028</pub-id></element-citation></ref>
<ref id="b25-mmr-11-06-4285"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berson</surname><given-names>JF</given-names></name><name><surname>Frank</surname><given-names>DW</given-names></name><name><surname>Calvo</surname><given-names>PA</given-names></name><etal/></person-group><article-title>A common temperature-sensitive allelic form of human tyrosinase is retained in the endoplasmic reticulum at the nonpermissive temperature</article-title><source>J Biol Chem</source><volume>275</volume><fpage>12281</fpage><lpage>12289</lpage><year>2000</year><pub-id pub-id-type="doi">10.1074/jbc.275.16.12281</pub-id><pub-id pub-id-type="pmid">10766867</pub-id></element-citation></ref>
<ref id="b26-mmr-11-06-4285"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>PW</given-names></name><name><surname>Oiso</surname><given-names>N</given-names></name><name><surname>Gautam</surname><given-names>R</given-names></name><etal/></person-group><article-title>The Hermansky-Pudlak syndrome 1 (HPS1) and HPS4 proteins are components of two complexes, BLOC-3 and BLOC-4, involved in the biogenesis of lysosome-related organelles</article-title><source>J Biol Chem</source><volume>278</volume><fpage>20332</fpage><lpage>20337</lpage><year>2003</year><pub-id pub-id-type="doi">10.1074/jbc.M300090200</pub-id><pub-id pub-id-type="pmid">12663659</pub-id></element-citation></ref>
<ref id="b27-mmr-11-06-4285"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kushimoto</surname><given-names>T</given-names></name><name><surname>Valencia</surname><given-names>JC</given-names></name><name><surname>Costin</surname><given-names>GE</given-names></name><etal/></person-group><article-title>The Seiji memorial lecture: the melanosome: an ideal model to study cellular differentiation</article-title><source>Pigment Cell Res</source><volume>16</volume><fpage>237</fpage><lpage>244</lpage><year>2003</year><pub-id pub-id-type="doi">10.1034/j.1600-0749.2003.00034.x</pub-id><pub-id pub-id-type="pmid">12753396</pub-id></element-citation></ref>
<ref id="b28-mmr-11-06-4285"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saffari</surname><given-names>Y</given-names></name><name><surname>Sadrzadeh</surname><given-names>SM</given-names></name></person-group><article-title>Green tea metabolite EGCG protects membranes against oxidative damage in vitro</article-title><source>Life Sci</source><volume>74</volume><fpage>1513</fpage><lpage>1518</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.lfs.2003.08.019</pub-id><pub-id pub-id-type="pmid">14729400</pub-id></element-citation></ref>
<ref id="b29-mmr-11-06-4285"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quevedo</surname><given-names>WC</given-names><suffix>Jr</suffix></name><name><surname>Holstein</surname><given-names>TJ</given-names></name><name><surname>Dyckman</surname><given-names>J</given-names></name><name><surname>McDonald</surname><given-names>CJ</given-names></name></person-group><article-title>The responses of the human epidermal melanocyte system to chronic erythemal doses of UVR in skin protected by topical applications of a combination of vitamins C and E</article-title><source>Pigment Cell Res</source><volume>13</volume><fpage>190</fpage><lpage>192</lpage><year>2000</year><pub-id pub-id-type="doi">10.1034/j.1600-0749.2000.130312.x</pub-id><pub-id pub-id-type="pmid">10885679</pub-id></element-citation></ref>
<ref id="b30-mmr-11-06-4285"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smit</surname><given-names>N</given-names></name><name><surname>Vicanova</surname><given-names>J</given-names></name><name><surname>Cramers</surname><given-names>P</given-names></name><name><surname>Vrolijk</surname><given-names>H</given-names></name><name><surname>Pavel</surname><given-names>S</given-names></name></person-group><article-title>The combined effects of extracts containing carotenoids and vitamins E and C on growth and pigmentation of cultured human melanocytes</article-title><source>Skin Pharmacol Physiol</source><volume>17</volume><fpage>238</fpage><lpage>245</lpage><year>2004</year><pub-id pub-id-type="doi">10.1159/000080217</pub-id><pub-id pub-id-type="pmid">15452410</pub-id></element-citation></ref>
<ref id="b31-mmr-11-06-4285"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bischoff</surname><given-names>SC</given-names></name></person-group><article-title>Quercetin: potentials in the prevention and therapy of disease</article-title><source>Curr Opin Clin Nutr Metab Care</source><volume>11</volume><fpage>733</fpage><lpage>740</lpage><year>2008</year><pub-id pub-id-type="doi">10.1097/MCO.0b013e32831394b8</pub-id><pub-id pub-id-type="pmid">18827577</pub-id></element-citation></ref>
<ref id="b32-mmr-11-06-4285"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>A</given-names></name><name><surname>Ashida</surname><given-names>H</given-names></name><name><surname>Terao</surname><given-names>J</given-names></name></person-group><article-title>Multitargeted cancer prevention by quercetin</article-title><source>Cancer Lett</source><volume>269</volume><fpage>315</fpage><lpage>325</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.canlet.2008.03.046</pub-id><pub-id pub-id-type="pmid">18467024</pub-id></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-mmr-11-06-4285" position="float">
<label>Figure 1</label>
<caption>
<p>Effect of H<sub>2</sub>O<sub>2</sub> on cell viability in human melanocytes. Human melanocytes were incubated for 24 h with various concentrations of H<sub>2</sub>O<sub>2</sub> (0&#x02013;400 <italic>&#x003BC;</italic>M) and cell viability was determined using an MTT assay. Treatment with 200 <italic>&#x003BC;</italic>M H<sub>2</sub>O<sub>2</sub> reduced cell viability by ~50% and was used for subsequent experiments. Values are presented as the mean &#x000B1; standard deviation (n=3). <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 vs. UT. H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide; UT, untreated group.</p></caption>
<graphic xlink:href="MMR-11-06-4285-g00.tif"/></fig>
<fig id="f2-mmr-11-06-4285" position="float">
<label>Figure 2</label>
<caption>
<p>Protective effect of quercetin against H<sub>2</sub>O<sub>2</sub> on melanocyte viability. Cells were incubated for 24 h with various concentrations of quercetin (0&#x02013;200 <italic>&#x003BC;</italic>M) following serum starvation. Significant protective effects were observed at 25 <italic>&#x003BC;</italic>M quercetin, therefore this concentration was used for subsequent experiments. Values are presented as the mean &#x000B1; standard deviation (n=3). <sup>&#x0002A;</sup>P&lt;0.01 vs. H<sub>2</sub>O<sub>2</sub>-treated cells. H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide.</p></caption>
<graphic xlink:href="MMR-11-06-4285-g01.tif"/></fig>
<fig id="f3-mmr-11-06-4285" position="float">
<label>Figure 3</label>
<caption>
<p>Detection of intracellular ROS levels. Human melanocytes were treated with 25 <italic>&#x003BC;</italic>M quercetin or NaOH in the presence or absence of 200 <italic>&#x003BC;</italic>M H<sub>2</sub>O<sub>2</sub>. ROS levels were determined by measuring the oxidative conversion of 2&#x02032;,7&#x02032;-dichlorofluorescin diacetate into DCF. ROS levels were normalized to that of untreated cells. <sup>&#x0002A;</sup>P&lt;0.05 vs. UT, <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 vs. UT. DCF, dichlorofluorescin; UT, untreated group; H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide.</p></caption>
<graphic xlink:href="MMR-11-06-4285-g02.tif"/></fig>
<fig id="f4-mmr-11-06-4285" position="float">
<label>Figure 4</label>
<caption>
<p>Morphological observations of the ER using electron microscopy. (A) Untreated cells, (B) H<sub>2</sub>O<sub>2</sub>-treated cells, (C) NaOH/H<sub>2</sub>O<sub>2</sub>-treated cells and (D) quercetin/H<sub>2</sub>O<sub>2</sub>-treated cells. ER dilation was observed in H<sub>2</sub>O<sub>2</sub>-treated and NaOH/H<sub>2</sub>O<sub>2</sub>-treated cells, while normal ER configuration was present in untreated and quercetin/H<sub>2</sub>O<sub>2</sub>-treated cells (magnification, &#x000D7;50,000). ER, endoplasmic reticulum; H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide.</p></caption>
<graphic xlink:href="MMR-11-06-4285-g03.tif"/></fig>
<fig id="f5-mmr-11-06-4285" position="float">
<label>Figure 5</label>
<caption>
<p>Characterization of tyrosinase and calreticulin co-localization using confocal laser scan microscopy. Merged images are shown in the last column (magnification, &#x000D7;400). Tyrosinase (green fluorescence), a key enzyme for melanin synthesis, and calreticulin (red fluorescence), an ER marker protein, are co-localized in the ER of the H<sub>2</sub>O<sub>2</sub> and NaOH/H<sub>2</sub>O<sub>2</sub> groups. Expression location of tyrosinase is beyond the endoplasmic reticulum marked by calreticulin. ER, endoplasmic reticulum; UT, untreated group; H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide.</p></caption>
<graphic xlink:href="MMR-11-06-4285-g04.tif"/></fig>
<fig id="f6-mmr-11-06-4285" position="float">
<label>Figure 6</label>
<caption>
<p>Quercetin protects melanocytes against H<sub>2</sub>O<sub>2</sub>-induced inhibition of tyrosinase expression. Following 24 h starvation, cell lysates were collected from melanocytes and western blot analysis was used to determine protein expression levels of tyrosinase and the internal control (&#x003B2;-actin). Values are presented as the mean &#x000B1; standard deviation. <sup>&#x0002A;</sup>P&lt;0.05 vs. UT, <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 vs. UT. UT, untreated group; H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide.</p></caption>
<graphic xlink:href="MMR-11-06-4285-g05.tif"/></fig></floats-group></article>
